Market Cap: $1.16B
SC
STAAR Surgical Company
STAA
NASDAQ (NASDAQ Global Market)USD
Market Cap: $1.16B
STAAR Surgical Company (Ticker: STAA) achieves remarkable revenue growth, signaling potential for continued success in the specialty medical device sector. The company reports a striking 120% increase…
Staar Surgical Company (Ticker: STAA) demonstrates significant growth in its first-quarter financial performance, reflecting a strategic focus on innovation and market expansion. The company's latest…
Advancing Compliance in AI: The Launch of STAAR 2.0 In the rapidly evolving landscape of artificial intelligence (AI), legal compliance remains paramount. Staar Surgical Company, as a key player in th…
Navigating AI Compliance: The Launch of STAAR 2.0 by Debevoise & Plimpton In a notable advancement for the legal technology landscape, Debevoise & Plimpton LLP unveils STAAR 2.0, an enhanced version o…
Staar Surgical Charts a Course for Growth Through Innovation in Eye Care Staar Surgical Company announces its fourth-quarter earnings for 2026, showcasing a substantial financial performance driven by…
Staar Surgical Poised for Earnings Report Highlighting Innovations in Ophthalmic Devices Staar Surgical Company, a prominent player in the ophthalmic device industry, prepares to unveil its quarterly…
Staar Surgical's Upcoming Earnings Report Highlights Innovative Growth Trajectory Staar Surgical Company, a leader in the ophthalmic device industry, is on the brink of releasing its quarterly earning…
FDA broadens age indication for Staar’s EVO/EVO+ Visian ICL Staar Surgical Company announces that the U.S. Food and Drug Administration approves an expanded age indication for its EVO and EVO+ Visian…
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon Defender Capital, a long-term shareholder of STAAR Surgical Company, publicly voices its opposition to the proposed sale of the company…
Defender Capital Voices Concerns Over STAAR Surgical's Proposed Sale to Alcon In a significant development for STAAR Surgical Company, Defender Capital, a long-term shareholder possessing approximatel…
Staar Surgical: Pioneering Innovations in Vision Correction Staar Surgical Company is at the forefront of transforming vision correction with its innovative implantable lens technology. The company sp…
Transforming Education: Abre's Partnership with Dallas ISD to Enhance Data Systems Abre, a prominent K-12 data platform, is making significant strides in educational technology through its expanding p…
Defender Capital Raises Concerns Over STAAR Surgical's Acquisition Offer Defender Capital, a notable shareholder of STAAR Surgical Company, strongly opposes the proposed acquisition by Alcon Inc. for…
Investigation into STAAR Surgical's Sale Raises Legal Concerns Halper Sadeh LLC, a law firm specializing in investor rights, initiates an investigation into STAAR Surgical Company regarding its recent…
Concerns Emerge Over STAAR Surgical's Proposed Acquisition by Alcon STAAR Surgical Company faces scrutiny regarding its proposed acquisition by Alcon, as Kaskela Law LLC initiates an investigation int…
Investor Advocacy Amidst Strategic Acquisitions in the Surgical Sector In recent developments, Staar Surgical Company finds itself at the center of a potential legal examination concerning its impendi…
Staar Surgical Under Scrutiny Amid Acquisition Deal In the backdrop of Staar Surgical Company’s impending acquisition by Alcon for $28.00 per share, investor rights law firm Halper Sadeh LLC is launch…
Investor Rights Firm Investigates STAAR Surgical’s Acquisition Deal In a significant development for STAAR Surgical Company, Halper Sadeh LLC, a law firm specializing in investor rights, initiates an…
Investigation into STAAR Surgical Highlights Shareholder Rights Concerns Halper Sadeh LLC, a law firm specializing in investor rights, launches an investigation into STAAR Surgical Company amidst its…
Halper Sadeh LLC Investigates STAAR Surgical's Pending Sale to Alcon Halper Sadeh LLC, a New York-based investor rights law firm, launches an investigation into STAAR Surgical Company concerning its p…
Staar Surgical Under Investigation Amid Sale to Alcon: Shareholder Rights at the Forefront Staar Surgical Company, known for its innovative eye care solutions, finds itself under the microscope as Hal…
Alcon's Strategic Acquisition of STAAR Surgical: A Leap Forward in Vision Correction Technologies In a significant move to enhance its position in the eye care market, Alcon Plc has announced its agre…
Staar Surgical Faces Legal Scrutiny Amid Earnings Report Fallout STAAR Surgical Company is currently under investigation by the Schall Law Firm, which specializes in shareholder rights litigation. Thi…
STAAR Surgical Company Reports Robust Sales Amid Challenges in China STAAR Surgical Company, renowned for its innovative EVO family of Implantable Collamer® Lenses (EVO ICL™), reveals its fourth quart…
STAAR Surgical Company Navigates Challenges Amid Strong Demand for ICL Technology STAAR Surgical Company, recognized as a leader in the field of phakic intraocular lenses (IOLs), particularly with its…